ResMed Inc. Files 8-K on Financials and Other Events
Ticker: RSMDF · Form: 8-K · Filed: Aug 1, 2024 · CIK: 943819
| Field | Detail |
|---|---|
| Company | Resmed Inc (RSMDF) |
| Form Type | 8-K |
| Filed Date | Aug 1, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.004, $0.53 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: RMD
TL;DR
ResMed dropped an 8-K, check it for the latest financial scoop.
AI Summary
ResMed Inc. filed an 8-K on August 1, 2024, reporting on its financial condition and other events. The filing includes financial statements and exhibits, but does not specify any particular transactions or financial results within the provided text.
Why It Matters
This filing provides an update on ResMed's financial condition and any significant events that have occurred, which is crucial for investors to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report and does not contain information indicating immediate or significant risks.
Key Players & Entities
- RESMED INC (company) — Registrant
- August 1, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 9001 Spectrum Center Blvd. San Diego , California 92123 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for ResMed Inc.?
The primary purpose of this 8-K filing is to report on ResMed Inc.'s Results of Operations and Financial Condition, as well as other events and financial statements and exhibits.
On what date was this 8-K filing made?
This 8-K filing was made on August 1, 2024.
In which state is ResMed Inc. incorporated?
ResMed Inc. is incorporated in Delaware.
What is the address of ResMed Inc.'s principal executive offices?
The address of ResMed Inc.'s principal executive offices is 9001 Spectrum Center Blvd. San Diego, California 92123.
What is ResMed Inc.'s telephone number?
ResMed Inc.'s telephone number is (858) 836-5000.
Filing Stats: 617 words · 2 min read · ~2 pages · Grade level 9.9 · Accepted 2024-08-01 16:05:55
Key Financial Figures
- $0.004 — nge on which registered Common Stock, $0.004 par value RMD NYSE Indicate by che
- $0.53 — eclared a quarterly cash dividend of US $0.53 per share. The dividend will have a rec
Filing Documents
- d805836d8k.htm (8-K) — 27KB
- d805836dex991.htm (EX-99.1) — 274KB
- g805836g0731004641176.jpg (GRAPHIC) — 2KB
- 0001193125-24-191487.txt ( ) — 447KB
- rmd-20240801.xsd (EX-101.SCH) — 3KB
- rmd-20240801_lab.xml (EX-101.LAB) — 18KB
- rmd-20240801_pre.xml (EX-101.PRE) — 11KB
- d805836d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibits: Description of Document 99.1 Press Release dated August 1, 2024, regarding results of operations 104 Cover Page Interactive Data File (embedded within the Inline XBRL, document) -2-
SIGNATURES
SIGNATURES We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934. Date: August 1, 2024 RESMED INC. (registrant) By: /s/ Brett Sandercock Name: Brett Sandercock Its: Chief Financial Officer -3-